LANTERN PHARMA INC's ticker is LTRN and the CUSIP is 51654W101. A total of 31 filers reported holding LANTERN PHARMA INC in Q4 2023. The put-call ratio across all filers is 2.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $6,253 | -78.8% | 1,339 | -60.1% | 0.00% | -100.0% |
| Q1 2024 | $29,533 | +492.8% | 3,356 | +188.3% | 0.00% | – |
| Q4 2023 | $4,982 | -21.3% | 1,164 | -37.3% | 0.00% | – |
| Q3 2023 | $6,332 | -52.0% | 1,857 | -20.6% | 0.00% | – |
| Q2 2023 | $13,192 | +131820.0% | 2,339 | +10.5% | 0.00% | – |
| Q1 2023 | $10 | – | 2,117 | +7460.7% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 28 | -99.3% | 0.00% | – |
| Q3 2022 | $19,000 | +216.7% | 3,817 | +238.7% | 0.00% | – |
| Q2 2022 | $6,000 | 0.0% | 1,127 | +45.8% | 0.00% | – |
| Q1 2022 | $6,000 | -53.8% | 773 | -52.0% | 0.00% | – |
| Q4 2021 | $13,000 | +116.7% | 1,612 | +204.2% | 0.00% | – |
| Q3 2021 | $6,000 | +20.0% | 530 | +50.6% | 0.00% | – |
| Q2 2021 | $5,000 | +400.0% | 352 | +467.7% | 0.00% | – |
| Q1 2021 | $1,000 | -90.9% | 62 | -89.5% | 0.00% | – |
| Q4 2020 | $11,000 | -15.4% | 593 | -16.4% | 0.00% | – |
| Q3 2020 | $13,000 | +550.0% | 709 | +317.1% | 0.00% | – |
| Q2 2020 | $2,000 | – | 170 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SANDERS MORRIS HARRIS LLC | 384,228 | $2,747,000 | 0.54% |
| CM Management, LLC | 33,765 | $241,000 | 0.20% |
| WOLFF WIESE MAGANA LLC | 36,155 | $259,000 | 0.17% |
| Redmond Asset Management, LLC | 49,793 | $356,000 | 0.11% |
| Carlson Capital, L.P. | 167,300 | $1,196,000 | 0.08% |
| NewEdge Advisors, LLC | 169,771 | $1,214,000 | 0.02% |
| Sigma Planning Corp | 17,600 | $126,000 | 0.00% |
| Spire Wealth Management | 4,050 | $29,000 | 0.00% |
| UBS Group AG | 13,936 | $100,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 3,075 | $22,000 | 0.00% |